Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Targeted cancer therapies often cause serious skin problems that need careful management.

Essential oils in cosmetics can offer benefits but may cause allergies and should be used carefully.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Oxidative stress contributes to hair graying and loss as we age.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Lithium therapy may cause skin problems like hidradenitis suppurativa and other side effects, which can improve after stopping the medication.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Cosmetics enhance beauty, fix defects, and intimidate enemies, with varying cultural standards and alternative methods.

The HoVert technique is a simple, cost-effective new method that improves alopecia diagnosis by allowing detailed analysis from a single biopsy.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

The study found that combining different databases gives a better estimate of drug side effects in hospitals.